Qube Research & Technologies Ltd

Position in COGT — Cogent Biosciences, Inc.

CIK 1729829 LONDON, X0

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,547,962

-$8,617,098 QoQ

Shares Held

169,198

-57.1% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#113

of 321 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. COGT ranks #64 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,547,962	169,198	-57.1%	Shares	Sole	2026-08-14
2026-03-31	$15,165,060	394,000	+42.4%	Shares	Sole	2026-05-15
2025-12-31	$9,829,378	276,728	+143.5%	Shares	Sole	2026-02-17
2025-09-30	$1,632,128	113,658	+501.3%	Shares	Sole	2025-11-14
2025-06-30	$135,716	18,902	-84.6%	Shares	Sole	2025-08-14
2024-03-31	$826,674	123,017	+5.0%	Shares	Sole	2024-05-14
2023-12-31	$688,947	117,168	+206.6%	Shares	Sole	2024-02-13
2021-09-30	$321,371	38,213	-31.3%	Shares	Sole	2021-11-12
2021-06-30	$450,810	55,587	+13.3%	Shares	Sole	2021-08-13
2021-03-31	$430,579	49,041	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.